During the past decade, Boston Center for Memory conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 11 clinical trials were completed, i.e. on average, 44% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 8 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Boston Center for Memory" #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Biogen" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "AstraZeneca" with 2 trials sponsored and "Avid Radiopharmaceuticals" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Boston Center for Memory" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Boston Center for Memory" with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Boston Center for Memory" are "Alzheimer Disease" (15 trials), "Alzheimer's Disease" (9 trials), "Cognitive Impairment" (4 trials), "Dementia" (3 trials) and "Cognitive Decline" (2 trials). Many other conditions were trialed in "Boston Center for Memory" in a lesser frequency.

Most popular intervention types in "Boston Center for Memory" are "Drug" (25 trials), "Device" (3 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Donanemab" (3 trials), "Gantenerumab" (3 trials), "Aducanumab" (2 trials) and "LY3202626" (2 trials). Other intervention names were less common.

The vast majority of trials in "Boston Center for Memory" are 29 trials for "All" genders.

Currently, there are NaN active trials in "Boston Center for Memory". undefined are not yet recruiting, 6 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Boston Center for Memory, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Boston Center for Memory, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".